ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC17362-50mg |
|
17560-51-9 |
Metolazone
|
0 | C16H16ClN3O3S | |
GC17361-10mg |
|
242143-80-2 |
Tabimorelin hemifumarate
|
0 | C32H40N4O3.½C4H4O4 | |
GC17360-50mg |
|
19728-88-2 |
Methiothepin maleate
|
0 | C20H24N2S2.C4H4O4 | |
GC17359-50mg |
|
1263369-28-3 |
CDK9 inhibitor 2
|
0 | C23H25ClFN5 | |
GC17359-10mg |
|
1263369-28-3 |
CDK9 inhibitor 2
|
0 | C23H25ClFN5 | |
GC17359-5mg |
|
1263369-28-3 |
CDK9 inhibitor 2
|
0 | C23H25ClFN5 | |
GC17358-10mg |
|
876150-14-0 |
Octyl-α-ketoglutarate
|
0 | C13H22O5 | |
GC17358-5mg |
|
876150-14-0 |
Octyl-α-ketoglutarate
|
0 | C13H22O5 | |
GC17358-1mg |
|
876150-14-0 |
Octyl-α-ketoglutarate
|
0 | C13H22O5 | |
GC17356-25g |
|
90-47-1 |
Xanthone
|
0 | C13H8O2 | |
GC17355-5mg |
|
61368-63-6 |
TNP-ATP triethylammonium salt
|
0 | C16H13N8O19P3.C24H64N4 | |
GC17354-10mg |
|
1673556-40-5 |
SW203668
|
0 | C22H19N3O2S | |
GC17354-5mg |
|
1673556-40-5 |
SW203668
|
0 | C22H19N3O2S | |
GC17354-1mg |
|
1673556-40-5 |
SW203668
|
0 | C22H19N3O2S | |
GC17353-500g |
|
127-09-3 |
Sodium acetate
|
0 | C2H3NaO2 | |
GC17352-10mg |
|
37558-16-0 |
Phorbol 12,13-dibutyrate
|
0 | C28H40O8 | |
GC17352-5mg |
|
37558-16-0 |
Phorbol 12,13-dibutyrate
|
0 | C28H40O8 | |
GC17352-1mg |
|
37558-16-0 |
Phorbol 12,13-dibutyrate
|
0 | C28H40O8 | |
GC17352-10mM (in 1mL DMSO) |
|
37558-16-0 |
Phorbol 12,13-dibutyrate
|
0 | C28H40O8 | |
GC17351-50mg |
|
6920-35-0 |
(±)-Hexanoylcarnitine chloride
|
0 | C13H26ClNO4 | |